Mucosal barrier injury–associated bloodstream infections in pediatric oncology patients-Reference-Cited by-同舟云学术

Mucosal barrier injury–associated bloodstream infections in pediatric oncology patients

Published:2020-05-09 Issue:8 Volume:67 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Hakim Hana¹^ORCID,Billett Amy L.²^ORCID,Xu Jiahui³,Tang Li³,Richardson Troy⁴,Winkle Cynthia⁵,Werner Eric J.⁶,Hord Jeffrey D.⁷^ORCID,Bundy David G.⁸,Gaur Aditya H.¹,

Affiliation:

1. Department of Infectious DiseasesSt. Jude Children's Research Hospital Memphis Tennessee

2. Department of OncologyDana‐Farber/Boston Children's Cancer and Blood Disorders Center Boston Massachusetts

3. Department of BiostatisticsSt. Jude Children's Research Hospital Memphis Tennessee

4. Children's Hospital Association Lenexa Kansas

5. Nursing DepartmentChildren's Medical Center Dallas Texas

6. Department of OncologyChildren's Specialty Group Norfolk Virginia

7. Department of OncologyAkron Children's Hospital Akron Ohio

8. Department of PediatricsMedical University of South Carolina Charleston South Carolina

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.28234

Reference24 articles.

1. Attributable mortality of central line associated bloodstream infection: systematic review and meta-analysis

2. The Centers for Disease Control and Prevention. National Healthcare Safety Network. Surveillance for Bloodstream Infections.https://www.cdc.gov/nhsn/acute-care-hospital/clabsi/index.html. Accessed February2019.

3. Distribution of Pathogens in Central Line–Associated Bloodstream Infections among Patients with and without Neutropenia following Chemotherapy Evidence for a Proposed Modification to the Current Surveillance Definition

4. Mucosal Barrier Injury Laboratory-Confirmed Bloodstream Infections (MBI-LCBI): Descriptive Analysis of Data Reported to National Healthcare Safety Network (NHSN), 2013

5. Mucosal Barrier Injury Laboratory-Confirmed Bloodstream Infection: Results from a Field Test of a New National Healthcare Safety Network Definition

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Implementing an Oral Health Educator Contributes to Reduced MBI-CLABSI Rates for Pediatric Hematopoietic Stem Cell Transplant Patients;The Joint Commission Journal on Quality and Patient Safety;2024-07

2. Impact of ciprofloxacin prophylaxis on blood stream infection during early treatment phase of pediatric acute lymphoblastic leukemia: An observational cohort study;EJC Paediatric Oncology;2024-06

3. Targeting ferroptosis unveils a new era for traditional Chinese medicine: a scientific metrology study;Frontiers in Pharmacology;2024-02-14

4. The applicability of the central line‐associated bloodstream infection (CLABSI) criteria for the evaluation of bacteremia episodes in pediatric oncology patients;European Journal of Haematology;2024-01-31

5. Emerging Resistance Trends in Viridans Group Streptococci Bloodstream Infections Among Immunocompromised Children Receiving Levofloxacin Prophylaxis;Journal of the Pediatric Infectious Diseases Society;2023-07-25